Home > Income Statement > CONCORD DRUGS

CONCORD DRUGS
Consolidated Net Profit

    Back to Income Statement
CONCORD DRUGS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CONCORD DRUGS
Please provide your vote to see the results

CONCORD DRUGS Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022
Consolidated Net Profit ₹0.34 Cr₹0.47 Cr₹0.99 Cr₹1.59 Cr

What is the latest Consolidated Net Profit of CONCORD DRUGS ?

The latest Consolidated Net Profit ratio of CONCORD DRUGS is ₹0.34 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹0.34 Cr
Mar2024₹0.47 Cr
Mar2023₹0.99 Cr
Mar2022₹1.59 Cr

How is Consolidated Net Profit of CONCORD DRUGS Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹0.34 Cr
-28.81
Mar2024 ₹0.47 Cr
-52.13
Mar2023 ₹0.99 Cr
-38.14
Mar2022 ₹1.59 Cr -

Compare Consolidated Net Profit of peers of CONCORD DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD DRUGS ₹94.0 Cr 1.4% -0.8% 28.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹467,630.0 Cr -0.1% 0.5% 14% Stock Analytics
DIVIS LABORATORIES ₹218,972.0 Cr -0.9% 21.1% 25.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,358.0 Cr -1.3% 1.1% 32.7% Stock Analytics
CIPLA ₹118,916.0 Cr 0.2% 2.1% -5.1% Stock Analytics
DR REDDYS LABORATORIES ₹97,824.0 Cr 0.2% -7.7% -7.5% Stock Analytics


CONCORD DRUGS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD DRUGS

1.4%

-0.8%

28.5%

SENSEX

0.5%

2.6%

-3.7%


You may also like the below Video Courses